title: Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine.
authors.forename: M
authors.initials: M
authors.lastname: Tzivras
authors.forename: A
authors.initials: A
authors.lastname: Konstandinidis
authors.forename: G
authors.initials: G
authors.lastname: Hatzis
authors.forename: K
authors.initials: K
authors.lastname: Paraskeva
authors.forename: N
authors.initials: N
authors.lastname: Skandalis
authors.forename: A
authors.initials: A
authors.lastname: Archimandritis
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000008:administration & dosage / Q000032:analysis* / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000494:pharmacology; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D008297:Male; D019804:Mesalamine; D008875:Middle Aged
chemical_list: D000636:Aminosalicylic Acids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine; C028836:N-acetyl-5-aminosalicylic acid; C032587:olsalazine